Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.99 -0.01 (-1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Return on Capital Employed [ROCE] (2012 - 2025)

Updated

Phio Pharmaceuticals (PHIO) recorded Return on Capital Employed [ROCE] of -66.68% in Q2 2025, up 126.61 percentage points from -193.30% a year earlier and up 18.06 percentage points from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Return on Capital Employed [ROCE] (2012 - 2025) Analysis & Trends

For FY2024, Phio Pharmaceuticals reported Return on Capital Employed [ROCE] of -113.02%, up 1.46 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -21.32 percentage points (FY2019 to FY2024).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -114.48% in FY2023 (-47.27 pp), -67.21% in FY2022 (+10.50 pp), -77.71% in FY2021 (+13.01 pp) and -90.71% in FY2020 (+0.98 pp).
  • The Q2 2025 figure is the highest quarterly Return on Capital Employed [ROCE] since Q1 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of -1.79 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 126.61 percentage points in Q2 2025, against a drop of 80.83 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -84.75% (Q1 2025), -154.33% (Q4 2024) and -163.30% (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Phio Pharmaceuticals 11.62 Mn 11.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -66.68%
Mar 31, 2025 -84.75%
Dec 31, 2024 -154.33%
Sep 30, 2024 -163.30%
Jun 30, 2024 -193.30%
Mar 31, 2024 -137.49%
Dec 31, 2023 -138.46%
Sep 30, 2023 -135.66%
Jun 30, 2023 -144.61%
Mar 31, 2023 -140.15%
Dec 31, 2022 -92.71%
Sep 30, 2022 -77.23%
Jun 30, 2022 -68.17%
Mar 31, 2022 -59.32%
Dec 31, 2021 -57.52%
Sep 30, 2021 -45.86%
Jun 30, 2021 -36.75%
Mar 31, 2021 -44.57%
Dec 31, 2020 -59.44%
Sep 30, 2020 -52.96%
API Access

Phio Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PHIO&period=max&api_key=YOUR_API_KEY